Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant
2024 · Molecular Therapy · 13 citations
https://doi.org/10.1016/j.ymthe.2024.10.016
S
Seok‐Chan Park
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
327
Citations
12
h-index
13
i10-index
Seok‐Chan Park is an academic researcher from Jeonbuk National University. The author has contributed to research in topics: Viral gastroenteritis research and epidemiology & SARS-CoV-2 and COVID-19 Research & Animal Virus Infections Studies. The author has an h-index of 12, co-authored 30 publications.
ORCID: 0000-0003-2489-2202Papers by this author
worksPortable UV-C device to treat high flow of infectious aerosols generated during clinical respiratory care
2024 · Scientific Reports · 2 citations
https://doi.org/10.1038/s41598-024-82901-x
Portable UV-C Device to Treat High Flow of Infectious Aerosols Generated during Clinical Respiratory Care
2024 · Research Square · 0 citations
https://doi.org/10.21203/rs.3.rs-4648863/v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat